Alexandria real estate equities, inc. enables the discovery, development and delivery of new innovative medicines that are key to addressing significant unmet medical need

Alexandria to lead mission-critical panel on immunology and inflammation as a cornerstone of treating human disease tomorrow at the 2024 galien forum usa at the alexandria center® for life science – new york city pasadena, calif. , nov. 6, 2024 /prnewswire/ -- alexandria real estate equities, inc. (nyse: are), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative mega campuses in aaa life science innovation cluster locations, continues to leverage its position at the vanguard and heart of the $5 trillion secularly growing life science industry to foster the development of new therapies and cures for the 10,000 diseases known to humankind, of which less than 10% are currently addressable with treatments.
ARE Ratings Summary
ARE Quant Ranking